Severe Congenital Heart Defects and Cerebral Palsy

Ester Garne1, Shona Goldsmith2, Ingeborg Barisic3

  • 1Department of Pediatrics and Adolescent Medicine, Lillebaelt Hospital, University Hospital of Southern Denmark, Kolding, Denmark.

PubMed

Insights

Children with severe congenital heart defects (sCHD) have a higher prevalence of cerebral palsy (CP). However, CP in these children tends to be milder than in those without congenital anomalies.

Area of Science:

  • Pediatric Neurology
  • Cardiology
  • Developmental Pediatrics

Background:

  • Cerebral palsy (CP) is a significant neurodevelopmental disorder.
  • Severe congenital heart defects (sCHD) are a known risk factor for adverse neurodevelopmental outcomes.
  • Understanding the interplay between sCHD and CP is crucial for early intervention and management.

Purpose of the Study:

  • To determine the prevalence of cerebral palsy (CP) in children with severe congenital heart defects (sCHD).
  • To describe the outcome and severity of CP in children with sCHD.
  • To compare CP characteristics in children with and without sCHD.

Main Methods:

  • A population-based data linkage study utilizing CP and congenital anomaly registers.
  • Inclusion of data from 4 European and 2 Australian regions (1991-2009).
  • Application of the EUROCAT definition for severe CHD (sCHD).

Main Results:

  • The prevalence of CP was 2.9 per 1000 births; sCHD prevalence was 2.1 per 1000 births.
  • 1.5% of children with sCHD also had CP (n=57).
  • Children with CP and sCHD more frequently presented with unilateral spastic CP and intellectual impairments compared to children with CP alone.

Conclusions:

  • The proportion of children with CP is significantly higher in those with sCHD compared to the general population.
  • CP in children with sCHD appears to be milder in severity than in children with CP without congenital anomalies.
  • This highlights the importance of neurodevelopmental surveillance in pediatric cardiology patients.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
199
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...
42.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
1.1K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
17